Assessment of morbidity from complete axillary dissection
- PMID: 1637663
- PMCID: PMC1977908
- DOI: 10.1038/bjc.1992.230
Assessment of morbidity from complete axillary dissection
Abstract
The importance of axillary dissection as part of the primary surgical procedure in the treatment of operable cases of carcinoma of the breast is established. The morbidity of this procedure, however, is less well documented. A study of 126 women who had had full axillary dissection as part of their initial surgical treatment was undertaken to assess their degree of morbidity in terms of numbness, pain, weakness, swelling, and stiffness. Seventy per cent of cases complained of numbness, 33% of pain, 25% of weakness, 24% of limb swelling, and 15% of stiffness. Objective measurements confirmed decreased sensation in 81%, weakness in 27%, swelling in 10%, and stiffness in 10%. In no case were these symptoms described as severe, though they did have an effect upon the daily lives of 39%. The side effects of full axillary dissection are common and all women should be warned of them prior to surgery; however they are usually mild and therefore should not preclude this procedure as a part of definitive surgical treatment.
Similar articles
-
Morbidity associated with axillary surgery for breast cancer.ANZ J Surg. 2004 May;74(5):314-7. doi: 10.1111/j.1445-1433.2004.02992.x. ANZ J Surg. 2004. PMID: 15144248
-
Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection.Oncol Nurs Forum. 2002 May;29(4):651-9. doi: 10.1188/02.ONF.651-659. Oncol Nurs Forum. 2002. PMID: 12011912
-
Physical and psychological morbidity after axillary lymph node dissection for breast cancer.J Clin Oncol. 1999 Jan;17(1):143-9. doi: 10.1200/JCO.1999.17.1.143. J Clin Oncol. 1999. PMID: 10458227
-
[Management of the axilla in breast cancer: evidences and unresolved issues].Orv Hetil. 2001 Sep 9;142(36):1941-50. Orv Hetil. 2001. PMID: 11680099 Review. Hungarian.
-
Is axillary lymph node dissection necessary in the routine management of breast cancer? Yes.Important Adv Oncol. 1996:245-50. Important Adv Oncol. 1996. PMID: 8791140 Review.
Cited by
-
Simple Prediction Model of Axillary Lymph Node Positivity After Analyzing Molecular and Clinical Factors in Early Breast Cancer.Medicine (Baltimore). 2016 May;95(20):e3689. doi: 10.1097/MD.0000000000003689. Medicine (Baltimore). 2016. PMID: 27196477 Free PMC article.
-
A Positive Node on Ultrasound-Guided Fine Needle Aspiration Predicts Higher Nodal Burden Than a Positive Sentinel Lymph Node Biopsy in Breast Carcinoma.World J Surg. 2016 Sep;40(9):2157-62. doi: 10.1007/s00268-016-3557-3. World J Surg. 2016. PMID: 27206399
-
Sentinel node biopsy should be supplemented by axillary sampling in patients with small breast cancers.Int Semin Surg Oncol. 2005 Nov 28;2:27. doi: 10.1186/1477-7800-2-27. Int Semin Surg Oncol. 2005. PMID: 16313679 Free PMC article.
-
Predicting axillary lymph node metastases in breast carcinoma patients.Breast Cancer Res Treat. 1996;37(2):135-49. doi: 10.1007/BF01806495. Breast Cancer Res Treat. 1996. PMID: 8750581
-
The Z0011 Trial: Is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients?Eur Radiol. 2015 Sep;25(9):2682-7. doi: 10.1007/s00330-015-3683-6. Epub 2015 Mar 5. Eur Radiol. 2015. PMID: 25740803
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical